The researchers have filed a patent on their method, SiMSen-seq, and are continuing to develop it, as well as a software tool, for oncology applications.
The QIAseq panels, which are available now, are the first of three major product launches Qiagen has planned for the second half of the year.
In early experiments, the method's raw single pass error rate was approximately 2 percent for a single target and up to 4 percent for a mixture of 10 targets.
The firm is nearing a market launch of the system, called the nanoAnalyzer 1000. The system is being developed for a variety of applications including genome assembly, structural variation analysis, and assessing DNA damage.
A Danish and Swedish-led research team reports that it has used a combination of nanochannels and denaturation to map so-called "barcode" patterns for labeled DNA.
Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.
Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.
In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.
Iceland has nearly eliminated Down syndrome from its population, CBS News reports.